These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2116817)

  • 21. Prevention of heterotopic ossification with irradiation after total hip arthroplasty. Radiation therapy with a single dose of eight hundred centigray administered to a limited field.
    Pellegrini VD; Konski AA; Gastel JA; Rubin P; Evarts CM
    J Bone Joint Surg Am; 1992 Feb; 74(2):186-200. PubMed ID: 1541613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of heterotopic bone formation with early post operative irradiation in high risk patients undergoing total hip arthroplasty: comparison of 10.00 Gy vs 20.00 Gy schedules.
    Anthony P; Keys H; Evarts CM; Rubin P; Lush C
    Int J Radiat Oncol Biol Phys; 1987 Mar; 13(3):365-9. PubMed ID: 3104246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indomethacin for prevention of ectopic ossification in cementless hip arthroplasties. A prospective 1-year study of 100 cases.
    Wurnig C; Eyb R; Auersperg V
    Acta Orthop Scand; 1992 Dec; 63(6):628-30. PubMed ID: 1471510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of the administration of diphosphonate for the prevention of heterotopic ossification after total hip arthroplasty.
    Thomas BJ; Amstutz HC
    J Bone Joint Surg Am; 1985 Mar; 67(3):400-3. PubMed ID: 3919028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of heterotopic ossification by nonsteroid antiinflammatory drugs after total hip arthroplasty.
    Sodemann B; Persson PE; Nilsson OS
    Clin Orthop Relat Res; 1988 Dec; (237):158-63. PubMed ID: 3142716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of heterotopic bone formation: clinical experience with diphosphonates.
    Thomas BJ; Amstutz HC
    Hip; 1987; ():59-69. PubMed ID: 3102407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy.
    Seegenschmiedt MH; Keilholz L; Martus P; Goldmann A; Wölfel R; Henning F; Sauer R
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):161-71. PubMed ID: 9300751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Eight days of naproxen therapy can prevent heterotopic ossification after total hip alloplasty].
    Gebuhr PH; Wilbek H; Soelberg M
    Ugeskr Laeger; 1996 Feb; 158(8):1076-8. PubMed ID: 8638341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naproxen in the prevention of heterotopic ossification after total hip replacement.
    Vielpeau C; Joubert JM; Hulet C
    Clin Orthop Relat Res; 1999 Dec; (369):279-88. PubMed ID: 10611883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification after total hip arthroplasty.
    Nilsson OS
    Semin Arthroplasty; 1992 Jul; 3(3):172-7. PubMed ID: 10147776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The use of radiotherapy in the prevention of heterotopic ossification in patients with total hip replacement].
    Marziano C; Pichi E; Chiarlone R; Luzi G; Siccardi C
    Radiol Med; 1996 Dec; 92(6):766-9. PubMed ID: 9122469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indomethacin for prevention of ectopic ossification after hip arthroplasty.
    Kjaersgaard-Andersen P; Schmidt SA
    Acta Orthop Scand; 1986 Feb; 57(1):12-4. PubMed ID: 3083642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of heterotopic ossification in cemented versus noncemented total hip joint replacement in patients with osteoarthrosis: a randomized clinical trial.
    Nayak KN; Mulliken B; Rorabeck CH; Bourne RB; Woolfrey MR
    Can J Surg; 1997 Oct; 40(5):368-74. PubMed ID: 9336527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indomethacin for prevention of heterotopic ossification after total hip arthroplasty.
    Tözün R; Pinar H; Yeşiller E; Hamzaoğlu A
    J Arthroplasty; 1992 Mar; 7(1):57-61. PubMed ID: 1564466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterotopic bone formation in total hip arthroplasty: predisposing factors, classification and the significance for clinical outcome.
    Schara K; Herman S
    Acta Chir Orthop Traumatol Cech; 2001; 68(2):105-8. PubMed ID: 11706718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Postoperative radiotherapy in the prevention of heterotopic ossification after endoprosthetic hip joint replacement].
    Heyd R; Strassmann G; Kirchner J; Schopohl B; Böttcher HD
    Strahlenther Onkol; 1996 Oct; 172(10):543-52. PubMed ID: 8966671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of periarticular heterotopic ossification following total hip arthroplasty. Clinical experience with indomethacin and ibuprofen.
    Sodemann B; Persson PE; Nilsson OS
    Arch Orthop Trauma Surg (1978); 1988; 107(6):329-33. PubMed ID: 3149179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naproxen for 8 days can prevent heterotopic ossification after hip arthroplasty.
    Gebuhr P; Wilbek H; Soelberg M
    Clin Orthop Relat Res; 1995 May; (314):166-9. PubMed ID: 7634631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical effect of etidronate disodium (EHDP) on heterotopic ossification following total hip arthroplasty.
    Yutani Y; Ohashi H; Nishimura N; Yamano Y
    Osaka City Med J; 1995 Dec; 41(2):63-73. PubMed ID: 8778647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects.
    Cella JP; Salvati EA; Sculco TP
    J Arthroplasty; 1988; 3(3):229-34. PubMed ID: 3141590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.